Hospital course A lumbar puncture showed nothing abnormal. Cultures of cerebrospinal fluid, blood, eyes, and throat were negative.
Therapy Because atypical cavernous sinus thrombosis was suspected, the patient was treated with oral ampicillin (250 mg. every 6 hours), diphenhydramine hydrochloride (75 mg. every 6 hours), and chloramphenicol (250 mg. every 6 hours) for 5 days with no response. On the sixth day, an exposure keratitis developed in the left eye, and the lids were taped shut. On the sevenlth and eighth days the keratitis improved, the exophthalmos subsided slightly, and some horizontal movement of the left eye coutld be elicited. Oral prednisone (6o mg. per day) was begtun and antibiotics wveie discontinued. Adams and Purves (1956) discovered another thyroid stimulator known as long-acting thyroid stimulator (LATS). This is a 7S gamma2 globulin consistent with an antibody, the antigen for which may reside in thyroid cells (Kriss and others, I967; Beall and Solomon, I966) . It has been detected in the thyroid cell cytoplasm using immunofluorescent techniques (Blum, Greenspan, Hargadine, and Lowenstein, I967) . It is not present in homogenates of the pituitary gland but is present in biopsy material from pretibial myxoedema.
LATS has been implicated in the development of endocrine ophthalmopathy (Kriss and others, I967; McKenzie, I965). Both the LATS level and the ophthalmopathy are independent of the thyroid status, appearing in euthyroid, hyperthyroid, and hypothyroid patients (McKenzie, 196I; Pimstone, Hoffenberg, and Black, I964) . Pretibial myxoedema frequently coincides with the ophthalmopathy. Kriss and others (I967) found that the severity of the ophthalmopathy as well as the pretibial myxoedema correlated with the level of circulating LATS. They also found, in a study of patients treated with I131, that the onset of the ophthalmopathy coincided with the appearance of LATS and developed most rapidly during the peak level of LATS. Kriss detected LATS in ten (27 per cent.) of 38 hyperthyroid patients. Ophthalmopathy was present in seven of the ten patients whose sera were LATS-positive. However, ophthalmopathv was found in only two of the 28 patients whose sera were LATS-negative.
Lipman, Green, Snyder, Nelson, and Solomon (I967) found that LATS was closely associated with the number of manifestations of Graves's disease present (i.e. hyperthyroidism, ophthalmopathy, dermopathy) rather than with any individual manifestation. The course of ophthalmopathy usually paralleled the course of LATS. Patients who had higher initial LATS levels or progressed to high levels had a poorer prognosis in regard to ophthalmopathy.
Orally-administered corticosteroids markedly depress the level of LATS and may decrease the ophthalmopathy and pretibial myxoedema (Hoffenberg and Jackson, I958; Snyder, Green, and Solomon, I964; Werner, I966). However, exacerbations (including reappearance of LATS) may occur with steroid withdrawal.
LATS is strongly associated with endocrine ophthalinopathy but has not been proved to be the CAUSE of ophthalmopathy (Lipman and others, I967; Werner, Feind, and Aida, I967) . It is also possible that a common aetiological factor causes both the presence of LATS and the ophthalmopathy.
The findings in our patient were consistent with endocrine ophthalmopathy. The LATS as well as the orbital signs disappeared with steroid treatment.
Summary
A long-acting thyroid stimulator (LATS) is related to endocrine ophthalmopathy. A i2-year-old Negro boy developed acute endocrine ophthalmopathy accompanied by a high serum titre of LATS which responded to corticosteroid therapy. 
